Aimmune Therapeutics Inc shareholders have backed Nestle's $2 billion offer to gain full ownership of the first U.S.-approved peanut allergy treatment, which has struggled with a slow launch due to the COVID-19 pandemic.
(RTTNews) - European stocks may open flat to slightly higher on Tuesday as investors pin hopes on U.S. stimulus and await U.S. bank results with JPMorgan and Citigroup kicking off the third-quarter earnings season later today.
AB de Villiers showed India the way to deal with Australia's pace attack ahead of their tour Down Under by flaying Pat Cummins in Monday's Indian Premier League (IPL) match, prompting his Bangalore captain Virat Kohli to dub him 'superman'.
Oil prices were steady on Tuesday, sitting on losses of nearly 3% from the previous session as supplies began to resume in Norway, the U.S. Gulf of Mexico and Libya, while the IEA forecast a 5% fall in global energy demand in 2020.
The dollar bounced back from a three-week low on Tuesday as market players bought it back, particularly against riskier peers, after Chinese authorities appeared to be trying to put a brake on recent rises in the yuan.
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) announced Tuesday that a pivotal Phase 3 trial of Dupixent (dupilumab) met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma.
Roche plans to start selling a higher-volume COVID-19 antigen test for laboratories by the end of the year as the Swiss drugmaker expands diagnostics for the pandemic.
The following company announcements, scheduled economic indicators, debt and currency market moves and political events may affect South African markets on Tuesday.
(RTTNews) - Asian stock markets are mostly lower on Tuesday despite the positive cues overnight from Wall Street reflecting gains by tech stocks and optimism about a new U.S. stimulus bill.
China's imports grew at their fastest pace this year in September, while exports extended their strong gains as more trading partners lifted coronavirus restrictions in a further boost to the world's second-biggest economy.
The clinical trial of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine candidate has been paused due to an unexplained illness in a study participant, according to an article published by STAT on Monday night. The independent data monitoring committee will be convened to rev
LONDON (Reuters Breakingviews) - Super-apps are associated with China’s internet giants and hot emerging market upstarts. As rivals like Facebook’s WhatsApp and old-world businesses like India’s Tata seek to burnish their all-in-one mobile application credentials,
Rafa Nadal's record of 13 French Open singles titles is one of sport's all-time greatest achievements and one that is unlikely to ever be broken, Andy Murray has said.
(RTTNews) - Johnson & Johnson (JNJ) has paused the phase III study of its COVID-19 vaccine candidate, JNJ-78436735, due to an unexplained illness in a study participant, Stat News reported, citing a document sent to outside researchers running the 60,000-patient clinical tri
Asian shares slipped on Tuesday, brushing off a firmer Wall Street lead as China's post-holiday rally cooled, although a buoyant tech sector and fresh optimism about U.S. stimulus are expected to continue to support sentiment.
New Zealand Rugby is expecting a "near-capacity" crowd of some 47,000 to pack into Auckland's Eden Park for the second Bledisloe Cup international against Australia on Sunday.
Entertainment powerhouse Walt Disney (NYSE: DIS) will soon look a bit different from an investor's perspective. The company just announced a sweeping reorganization of its media and entertainment operations, focusing Disney's considerable assets more directly on streaming media
Williams-Sonoma (NYSE: WSM) announced that its board of directors has elected to increase its quarterly dividend. The new payout will be $0.53 per share, which is just over 10% higher than the last hike. It will be dispensed on Nov. 27 to investors of record as of Oct. 23. At th